A commercially astute and resilient senior business leader with strong influencing, interpersonal and communication skills. Currently working strategically at C-suite level with the agility to quickly flex to solve day to day operational challenges. Demonstrable track record of building profitable business units and strategic new revenue streams underpinned by excellent operational delivery through the development of high performance teams. Experience of turnarounds through restructuring and strategic pivots. A PhD and MBA-trained innovative leader with strong exposure to the drug development process from blue skies research, pre-clinical, clinical to market and patient access. NED (Finance & Audit Committee) for multimillion US Non-for-Profit. Former Industry Advisor for UK University.Regular speaker at international conferences.